| scholarly article | Q13442814 |
| editorial | Q871232 |
| P356 | DOI | 10.1007/BF01212724 |
| P698 | PubMed publication ID | 8440743 |
| P2093 | author name string | E Tahara | |
| P2860 | cites work | Identification of deletion mutations and three new genes at the familial polyposis locus | Q24294229 |
| Molecular cloning and expression of human hepatocyte growth factor | Q24305558 | ||
| Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product | Q24310794 | ||
| Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors | Q24339620 | ||
| Molecular characterization of a gene of the 'EGF family' expressed in undifferentiated human NTERA2 teratocarcinoma cells | Q24567485 | ||
| A genetic model for colorectal tumorigenesis | Q27860582 | ||
| Identification of a chromosome 18q gene that is altered in colorectal cancers | Q28274172 | ||
| Identification of FAP locus genes from chromosome 5q21 | Q28300247 | ||
| Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients | Q28300256 | ||
| The 102 kd cadherin-associated protein: similarity to vinculin and posttranscriptional regulation of expression | Q28302135 | ||
| p53 mutations in human cancers | Q28302973 | ||
| Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system | Q28304498 | ||
| Expression cloning and characterization of the TGF-beta type III receptor | Q28304515 | ||
| K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes | Q28609638 | ||
| Structure and function of telomeres | Q29615759 | ||
| Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death | Q29620000 | ||
| Identification and characterization of the familial adenomatous polyposis coli gene | Q29620382 | ||
| Cloning and expression of genes for the Oxytricha telomere-binding protein: specific subunit interactions in the telomeric complex | Q30445933 | ||
| Two rearranged MET alleles in MNNG-HOS cells reveal the orientation of MET on chromosome 7 to other markers tightly linked to the cystic fibrosis locus | Q33567327 | ||
| Frequent mutation of the p53 gene in human esophageal cancer | Q33927516 | ||
| Telomere reduction in human colorectal carcinoma and with ageing | Q34037761 | ||
| The human met oncogene is related to the tyrosine kinase oncogenes | Q34201032 | ||
| Analysis by pulsed field gel electrophoresis reveals complex rearrangements in two MET alleles in a chemically-treated human cell line, MNNG-HOS. | Q34234846 | ||
| Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population | Q34550966 | ||
| tpr-met oncogene product induces maturation-producing factor activation in Xenopus oocytes | Q36743308 | ||
| K-sam gene encodes secreted as well as transmembrane receptor tyrosine kinase | Q36930426 | ||
| Characterization of the TPR-MET oncogene p65 and the MET protooncogene p140 protein-tyrosine kinases | Q37479257 | ||
| The TPR-MET oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions | Q37525133 | ||
| BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death | Q37572590 | ||
| Growth factors and oncogenes in human gastrointestinal carcinomas | Q37876172 | ||
| Identification of a Competitive HGF Antagonist Encoded by an Alternative Transcript | Q38332144 | ||
| Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET | Q41152225 | ||
| Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase | Q41639273 | ||
| Scatter factor and hepatocyte growth factor: activities, properties, and mechanism | Q41646862 | ||
| Reduced Levels of Transforming Growth Factor‐beta Type I Receptor in Human Gastric Carcinomas | Q41651227 | ||
| Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor | Q41656206 | ||
| p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases. | Q41657557 | ||
| Expression of the Met/HGF receptor in normal and neoplastic human tissues | Q41658755 | ||
| Expression of cripto, a novel gene of the epidermal growth factor family, in human gastrointestinal carcinomas | Q41666047 | ||
| Occurrence of p53 gene abnormalities in gastric carcinoma tumors and cell lines | Q41675516 | ||
| An alternatively processed mRNA generated from human hepatocyte growth factor gene. | Q41687910 | ||
| Expression of cripto, a novel gene of the epidermal growth factor gene family, leads to in vitro transformation of a normal mouse mammary epithelial cell line | Q41697997 | ||
| Expression of basic fibroblast growth factor in human gastric carcinomas | Q41707367 | ||
| Expression of ERBB2 in human gastric carcinomas: relationship between p185ERBB2 expression and the gene amplification | Q41710662 | ||
| Induction of growth factor-receptor and metalloproteinase genes by epidermal growth factor and/or transforming growth factor-alpha in human gastric carcinoma cell line MKN-28. | Q41726438 | ||
| Isolation of an amplified DNA sequence in stomach cancer | Q41726449 | ||
| The APC gene, responsible for familial adenomatous polyposis, is mutated in human gastric cancer | Q41897052 | ||
| Alterations of oncogenes in metastatic tumours of human gastric carcinomas | Q42281667 | ||
| The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors | Q42473244 | ||
| p53 point mutations in primary human gastric carcinomas | Q42604914 | ||
| Mechanism of met oncogene activation | Q42811433 | ||
| The activated human met gene encodes a protein tyrosine kinase | Q43762584 | ||
| Growth inhibition of transforming growth factor beta on human gastric carcinoma cells: receptor and postreceptor signaling | Q44586016 | ||
| Molecular cloning of a new transforming gene from a chemically transformed human cell line. | Q45345810 | ||
| Genetic abnormalities and expression of p53 in human colon carcinomas. | Q47758369 | ||
| Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis. | Q53498111 | ||
| Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas. | Q53498117 | ||
| Evidence for non-covalent clusters of the c-met proto-oncogene product | Q54269961 | ||
| Coexpression of platelet-derived growth factor (PDGF) A-chain and PDGF receptor genes in human gastric carcinomas. | Q54985682 | ||
| p53 expression and prognosis in gastric carcinoma | Q57416537 | ||
| Association of ki-ras mutation with differentiation and tumor-formation pathways in colorectal carcinoma | Q58409266 | ||
| Ki-ras oncogene activation in preinvasive pancreatic cancer | Q67485492 | ||
| The new era of cancer epidemiology | Q67911589 | ||
| Frequent loss of heterozygosity at the DCC locus in gastric cancer | Q68133873 | ||
| Many gene changes found in cancer | Q69400051 | ||
| Expression of TGF-beta and procollagen type I and type III in human gastric carcinomas | Q69722347 | ||
| Expression of E- and P-cadherin in gastric carcinomas | Q70127603 | ||
| Tumor production in the glandular stomach and alimentary tract of the rat by N-methyl-N'-nitro-N-nitrosoguanidine | Q71541533 | ||
| P433 | issue | 5 | |
| P921 | main subject | carcinogenesis | Q1637543 |
| P304 | page(s) | 265-272 | |
| P577 | publication date | 1993-01-01 | |
| P1433 | published in | Journal of Cancer Research and Clinical Oncology | Q2081599 |
| P1476 | title | Molecular mechanism of stomach carcinogenesis. | |
| P478 | volume | 119 |
| Q73683259 | 17q12-21 amplicon, a novel recurrent genetic change in intestinal type of gastric carcinoma: a comparative genomic hybridization study |
| Q80408538 | A high expression level of insulin-like growth factor I receptor is associated with increased expression of transcription factor Sp1 and regional lymph node metastasis of human gastric cancer |
| Q33909710 | A p53 genetic polymorphism of gastric cancer: difference between early gastric cancer and advanced gastric cancer |
| Q54667326 | A single nucleotide polymorphism in the 5' untranslated region of the EGF gene is associated with occurrence and malignant progression of gastric cancer. |
| Q40783581 | Absence of tpr-met and expression of c-met in human gastric mucosa and carcinoma. |
| Q30891486 | Activation of ErbB3-PI3-kinase pathway is correlated with malignant phenotypes of adenocarcinomas |
| Q33944994 | Adenocarcinoma of the stomach: a review |
| Q46083534 | Analysis of genetic alterations associated with DNA diploidy, aneuploidy and multiploidy in gastric cancers |
| Q45139903 | Analysis of p53 mutations and Helicobacter pylori infection in human and animal models |
| Q36537743 | Association between Genetic Instability and Helicobacter pylori Infection in Gastric Epithelial Dysplasia |
| Q45187256 | Association of the -160 C --> a promoter polymorphism of E-cadherin gene with gastric carcinoma risk |
| Q71216840 | Bcl-2 expression and allelic loss of the p53 gene in gastric carcinomas |
| Q41867381 | Bcl-2 expression in human melanocytes and melanocytic tumors |
| Q35774292 | Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation |
| Q59182812 | Classification of gastric carcinomas |
| Q36836007 | Clinicopathological and molecular characteristics of gastric and colorectal carcinomas in the elderly |
| Q73966995 | Clinicopathological implication of cripto expression in early stage invasive cervical carcinomas |
| Q36432629 | Clinicopathological significance of NMIIA overexpression in human gastric cancer |
| Q28512980 | Contribution of gastrin-releasing peptide and its receptor to villus development in the murine and human gastrointestinal tract |
| Q41066248 | Correlation of hepatocyte growth factor-induced proliferation and calcium-activated potassium current in human gastric cancer cells |
| Q37135934 | Correlation of p53 over-expression and alteration in p53 gene detected by polymerase chain reaction-single strand conformation polymorphism in adenocarcinoma of gastric cancer patients from India |
| Q43119157 | DNA methylation and carcinogenesis in digestive neoplasms. |
| Q35691577 | Differences in genetic instability and cellular phenotype among Barrett's, cardiac, and gastric intestinal metaplasia in a Japanese population with Helicobacter pylori |
| Q50531120 | Differential expression of apoptosis receptors on diffuse and intestinal type stomach carcinoma. |
| Q71420571 | Differential p53 protein expression in stomach adenomas of gastric and intestinal phenotypes: possible sequences of p53 alteration in stomach carcinogenesis |
| Q47886471 | Distant metastasis of gastric cancer is associated with elevated expression of the antimetastatic nm23 gene |
| Q37229811 | Double immunostaining for p53 and molecular chaperone hsp72/73 in gastric carcinoma |
| Q43774891 | Effect of Helicobacter pylori infection on gastric cell proliferation and genomic instability in a paediatric population of southern Italy. |
| Q72785129 | Effect of hepatocyte growth factor on the expression of E- and P-cadherin in gastric carcinoma cell lines |
| Q50974657 | Endocrine carcinoma of the stomach: clinicopathological analysis of 27 surgically treated cases in a single institute. |
| Q73707441 | Expression of Bcl-2 protein in human primary breast carcinomas and its correlation with multifocality, histopathological types and prognosis |
| Q53439664 | Expression of immunohistochemical markers according to histological type in patients with early gastric cancer. |
| Q55052578 | Expression of interleukin-6 and its effect on the cell growth of gastric carcinoma cell lines. |
| Q35764209 | Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. |
| Q36620052 | Expression of nuclear retinoid receptors in normal, premalignant and malignant gastric tissues determined by in situ hybridization |
| Q47759636 | Expression of telomerase activity, human telomerase RNA, and telomerase reverse transcriptase in gastric adenocarcinomas |
| Q42590325 | Expression of transforming growth factor alpha, epidermal growth factor receptor and epidermal growth factor in precursor lesions to gastric carcinoma |
| Q41332206 | Frequent amplification of the cyclin E gene in human gastric carcinomas |
| Q48049939 | Frequent detection of aberrant RNA transcripts of the CDKN2 gene in human gastric adenocarcinoma |
| Q71796173 | Gastric adenoma ? carcinoma sequence with special reference to p53 and Ki-ras gene alterations |
| Q71510076 | Gastric cancer |
| Q34730186 | Gastric cancer: pathogenesis, risks, and prevention |
| Q64891812 | Gastric carcinogenesis. |
| Q55374618 | Gastric tumor induction by 1,2-dimethylhydrazine in Wistar rats with intestinal metaplasia caused by X-irradiation. |
| Q55215472 | Gastric tumorigenicity of 1,2-dimethylhydrazine on the background of gastric intestinal metaplasia induced by X-irradiation in CD (SD) rats. |
| Q73515245 | Genetic alterations of gastric cancer: comparative genomic hybridization and fluorescence In situ hybridization studies |
| Q34177743 | Genetic and epigenetic changes in stomach cancer |
| Q35746434 | Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta |
| Q35587228 | Genetic evolution of alpha fetoprotein producing gastric cancer |
| Q33918298 | Genetic instability in gastric epithelial neoplasias categorized by the revised vienna classification |
| Q34410374 | Global DNA hypomethylation occurs in the early stages of intestinal type gastric carcinoma |
| Q77407561 | Helicobacter pylori and gastric cancer |
| Q78036365 | Histopathological analysis of apoptosis, and expression of p53, bcl-2, bax, and Ki-67 in laryngeal squamous cell carcinomas and dysplasia |
| Q74720116 | Image cytometric bcl-2:bax and bcl-2:bcl-x ratios in invasive breast carcinoma: correlation with prognosis |
| Q37223899 | Immunohistochemical evaluation of keratin 20 expression in intestinal metaplasia types I to III. |
| Q73454390 | Immunohistochemical studies on EGF family growth factors in normal and ulcerated human gastric mucosa |
| Q39522102 | In vivo and in vitro studies of cytosolic phospholipase A2 expression in Helicobacter pylori infection |
| Q41152333 | Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines |
| Q38914344 | Inactivation of the phosphatidylinositol 3-kinase/Akt pathway is involved in BMP9-mediated tumor-suppressive effects in gastric cancer cells |
| Q42513057 | Increased apoptosis associated with depressed type of early intestinal gastric cancer |
| Q45763261 | Infrequent overexpression of p53 protein in Epstein-Barr virus-associated gastric carcinomas |
| Q85209596 | Interleukin-10 −1082 promoter polymorphism and gastric cancer risk in a Chinese Han population |
| Q35747605 | Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma |
| Q73651411 | Is there a link between environmental factors and a genetic predisposition to cancer? A lesson from a familial cluster of gastric cancers |
| Q41384958 | K-ras mutations and cell kinetics in Helicobacter pylori associated gastric intestinal metaplasia: a comparison before and after eradication in patients with chronic gastritis and gastric cancer |
| Q55057897 | Lack of any positive effect of intestinal metaplasia on induction of gastric tumors in Wistar rats treated with N-methyl-N-nitrosourea in their drinking water. |
| Q36961820 | Latent membrane protein 2A inhibits transforming growth factor-beta 1-induced apoptosis through the phosphatidylinositol 3-kinase/Akt pathway |
| Q44386099 | Loss of FHIT protein expression correlates with disease progression and poor differentiation in gastric cancer |
| Q53295389 | Loss of Reprimo and S100A2 expression in human gastric adenocarcinoma |
| Q55160316 | Loss of heterozygosity at the bcl-2 gene locus and expression of bcl-2 in human gastric and colorectal carcinomas. |
| Q74272476 | Mapping of a new target region of allelic loss at 21q22 in primary gastric cancers |
| Q40937231 | Merkel cells and Merkel cell carcinoma express the BCL-2 proto-oncogene |
| Q57826840 | Merkel cells and Merkel cell carcinoma express the BCL-2 proto-oncogene |
| Q39016865 | MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer |
| Q45741640 | Microsatellite instability and Epstein-Barr virus infection in gastric remnant cancers |
| Q35938600 | Microsatellite instability in Korean patients with gastric adenocarcinoma |
| Q35798312 | Microsatellite instability in adenocarcinomas of the upper gastrointestinal tract. Relation to clinicopathological data and family history |
| Q35481226 | Microsatellite instability is associated with the clinicopathologic features of gastric cancer in sporadic gastric cancer patients |
| Q72063761 | Molecular biology of gastric cancer |
| Q33816796 | Molecular biology of gastric carcinoma: from laboratory to bedside. |
| Q34099128 | Molecular characteristics of eight gastric cancer cell lines established in Japan |
| Q38362385 | Molecular diagnosis of p53 mutations in gastric carcinoma by touch preparation |
| Q34224839 | Molecular markers predictive of response to chemotherapy in gastrointestinal tumors. |
| Q77449502 | Molecular mechanism of human stomach carcinogenesis implicated in Helicobacter pylori infection |
| Q33742739 | Molecular-pathological diagnosis of gastrointestinal tissues and its contribution to cancer histopathology |
| Q42412808 | Mucin phenotype of gastric cancer and clinicopathology of gastric-type differentiated adenocarcinoma |
| Q43066602 | Multiple genetic alterations and behavior of cellular biology in gastric cancer and other gastric mucosal lesions:H.pylori infection, histological types and staging |
| Q71743165 | Mutations of the transforming growth factor beta type II receptor gene and microsatellite instability in gastric cancer |
| Q58408445 | Métalloprotéases de la matrice extracellulaire et cancers du tractus digestif |
| Q55003665 | N-methyl-N-nitrosourea concentration-dependent, rather than total intake-dependent, induction of adenocarcinomas in the glandular stomach of BALB/c mice. |
| Q40483559 | News of TNM and its use for classification of gastric cancer |
| Q71119374 | Numerical aberration and point mutation of p53 gene in human gastric intestinal metaplasia and well-differentiated adenocarcinoma: analysis by fluorescence in situ hybridization (FISH) and PCR-SSCP |
| Q34424883 | Odd-skipped related 1 is a novel tumour suppressor gene and a potential prognostic biomarker in gastric cancer. |
| Q43979786 | Oncogenic T-antigen of JC virus is present frequently in human gastric cancers. |
| Q37682026 | Overexpression of ADP-ribosylation factor 1 in human gastric carcinoma and its clinicopathological significance |
| Q36695184 | Overexpression of SPARC gene in human gastric carcinoma and its clinic-pathologic significance |
| Q43289848 | Overexpression of protein phosphatase non-receptor type 11 (PTPN11) in gastric carcinomas |
| Q41666155 | Overexpression of the p53 tumor suppressor gene product in esophageal and gastric carcinomas |
| Q34194142 | P53 Codon 72 polymorphisms: a case-control study of gastric cancer and potential interactions |
| Q53365184 | P53 and Rb tumor suppressor gene alterations in gastric cancer. |
| Q55196406 | Pathological characteristics of gastric carcinomas in the very old. |
| Q26866200 | Potential prognostic, diagnostic and therapeutic markers for human gastric cancer |
| Q53429214 | Presence of high-level DNA copy number gains in gastric carcinoma and severely dysplastic adenomas but not in moderately dysplastic adenomas. |
| Q53477859 | Primary gastric carcinoma cells frequently lose heterozygosity at the APC and MCC genetic loci. |
| Q40784270 | Promoter hypermethylation of MGMT is associated with protein loss in gastric carcinoma |
| Q53722723 | Protein kinase Cι is a new prognostic factor in gastric cancer. |
| Q44683323 | Risk factors for cancer development in Helicobacter pylori gastritis |
| Q92527747 | Role of HGF/c-Met in the treatment of colorectal cancer with liver metastasis |
| Q31059425 | Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications |
| Q73488806 | Strain differences in the induction of intestinal metaplasia by X-irradiation in rats |
| Q83498036 | Telomere shortening occurs early during gastrocarcinogenesis |
| Q34224909 | The case for gastrin-releasing peptide acting as a morphogen when it and its receptor are aberrantly expressed in cancer |
| Q41072653 | The clinical significance of malfunction of the CD44 locus in malignancy |
| Q35753518 | The clinicopathological features of gastric carcinomas with microsatellite instability may be mediated by mutations of different "target genes": a study of the TGFbeta RII, IGFII R, and BAX genes |
| Q37448891 | The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer |
| Q34274752 | The influence of transforming growth factor-α, cyclooxygenase-2, matrix metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in epithelial-mesenchymal transition on overall survival of patients with gastric cancer |
| Q34348345 | The use of molecular biology in diagnosis and prognosis of gastric cancer |
| Q47576870 | Three independent genetic profiles based on mucin expression in early differentiated-type gastric cancers--a new concept of genetic carcinogenesis of early differentiated-type adenocarcinomas |
| Q36619660 | Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice |
| Q58197500 | Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility |
| Q34225724 | Up-regulation of cytoskeletal-associated protein 2 in primary human gastric adenocarcinomas. |
| Q40818822 | Urinary bladder lesions after the Chernobyl accident: immunohistochemical assessment of p53, proliferating cell nuclear antigen, cyclin D1 and p21WAF1/Cip1. |
| Q73743182 | c-erbB2 and p53 expression are not associated with stage progression of gastric cancer in Britain or Japan |
| Q44290770 | p16 hypermethylation during gastric carcinogenesis of Wistar rats by N-methyl-N'-nitro-N-nitrosoguanidine |
| Q54407212 | p53 Codon 72 Polymorphism and Gastric Cancer Risk in a Chinese Han Population |
| Q54379652 | p53 codon 72 polymorphism in patients with gastric and colorectal cancer in a Korean population. |
| Q74082565 | p53 expression in gastric cancer: clinicopathological correlation and prognostic significance |
Search more.